Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patients.
Wijnands
M J
MJ
Dept. of Rheumatology, University Hospital Nijmegen, The Netherlands.
Nuver-Zwart
I H
IH
van Riel
P L
PL
van 't Hof
M A
MA
Gribnau
F W
FW
van De Putte
L B
LB
D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006242:Haptoglobins / Q000032:analysis; D006454:Hemoglobins / Q000032:analysis; D006461:Hemolysis; D006466:Hemopexin / Q000032:analysis; D006801:Humans; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D006242:Haptoglobins; D006454:Hemoglobins; D012460:Sulfasalazine; D006466:Hemopexin